Development of bio-engineered drugs in active stage

Market analysts say that the development of bio-engieered drugs is making the brisk pace in the domestic market, since many potential drugs are expected to be under clinical trials, following the market approval of Chondron, an anti-arthritic treatment.

The Korea Food and Drug Administration (KFDA) granted its approval on Chondron of Cellontech, an autologus chondrocyte transplant therapy, f...